Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

05/02/2021 06:00

Feb 5 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.42               10.07            14.81    
                 (+3.5 pct)          (-17.7 pct)      (+1.7 pct)  
  Operating          1.63                1.58             1.80    
                 (+3.1 pct)         (+361.2 pct)      (-19.2 pct) 
  Recurring          1.65                2.14             2.20    
                 (-23.1 pct)        (+111.0 pct)      (-29.5 pct) 
  Net                1.48                1.61             1.80    
                 (-8.0 pct)          (+2.6 pct)       (-29.4 pct) 
  EPS             35.47 yen           38.56 yen        43.23 yen  
  Ann Div                             5.00 yen         5.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             5.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T